Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2025 04:00 ET | Source: MSInsight

MSInsight se joint au projet PREDI-LYNCH, une initiative européenne pour permettre d’identifier plus tôt les porteurs du syndrome de Lynch, l’une des principales prédispositions héréditaires au cancer.

Communiqué de presse Paris, 29 septembre 2025 – MSInsight, start-up française de médecine de précision en oncologie, annonce sa participation au projet européen PREDI-LYNCH, un consortium...
September 30, 2025 04:00 ET | Source: MSInsight

MSInsight Joins PREDI-LYNCH Project to Advance Non-Invasive Cancer Detection in Lynch Syndrome — Aligning With Hereditary Cancer Awareness Week

Press Release Paris, September 2025 – MSInsight, a French precision oncology start-up, is proud to announce its participation in PREDI-LYNCH*, a six-year Horizon Europe consortium led by Oslo...
August 20, 2025 16:50 ET | Source: Larkspur Biosciences, Inc.

Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting

Larkspur Biosciences Announces Discovery of LRK-4189, 1st-in-Class Degrader of Lipid Kinase PIP4K2C, for Treatment of MSS CRC at ACS Fall 2025 Meeting
April 15, 2025 08:00 ET | Source: Alberta Cancer Foundation

Alberta Cancer Foundation partners with CDL Cancer to advance oncology innovation

Alberta Cancer Foundation (ACF) is joining the Creative Destruction Lab Cancer program to accelerate commercialization of tech to transform cancer care.
March 10, 2025 12:45 ET | Source: MSInsight

MSInsight annonce une levée de fonds d’amorçage de 1,6 M€ pour révolutionner le diagnostic des cancers MSI

Communiqué de presse Paris, le 12 mars 2025 – MSInsight, start-up innovante spécialisée dans la médecine de précision en oncologie, annonce la réussite de son tour de financement d’amorçage d'un...
March 10, 2025 12:45 ET | Source: MSInsight

MSInsight Announces €1.6 Million in Seed Fundraising to Revolutionize MSI Cancer Diagnosis

Press Release Paris, March 12, 2025 – MSInsight, an innovative start-up specializing in precision medicine in oncology, announces the successful completion of its €1.6 million seed funding round....